![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1765285
¼¼°èÀÇ Á¶Á÷ ó¸® ½Ã½ºÅÛ ½ÃÀåTissue Processing Systems |
Á¶Á÷ ó¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 5¾ï 7,010¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2024³â¿¡ 4¾ï 3,380¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Á¶Á÷ ó¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 4.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 7,010¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼Ò¿ë·® ºÎ¹®Àº CAGR 4.4%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 5,130¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á߿뷮 ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.9%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº 1¾ï 1,710¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.4%·Î ¼ºÀå ¿¹Ãø
¹Ì±¹ÀÇ Á¶Á÷ ó¸® ½Ã½ºÅÛ ½ÃÀåÀº 2024³â¿¡ 1¾ï 1,710¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 4.4%·Î 2030³â±îÁö ¿¹Ãø ½ÃÀå ±Ô¸ð 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.3%¿Í 3.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR 4.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ Á¶Á÷ ó¸® ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®
Á¶Á÷ ó¸® ½Ã½ºÅÛÀÌ º´¸® Áø´Ü¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?
Á¶Á÷ ó¸® ½Ã½ºÅÛÀº º´¸® °Ë»ç½Ç¿¡¼ »ýü Á¶Á÷À» °Ë»ç, Áø´Ü ¹× ¿¬±¸¸¦ À§ÇØ ÀûÀýÇÏ°Ô ÁغñÇϱâ À§ÇÑ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ °úÁ¤¿¡¼ Á¶Á÷ »ùÇÃÀ» °íÁ¤, Å»¼ö, Åõ¸íÈ, ÆÄ¶óÇÉ ¿Î½º¿¡ Æ÷¸ÅÇÏ¿© Á¶Á÷ÇÐÀÚ¿Í º´¸®ÇÐÀÚ°¡ Çö¹Ì°æ °Ë»ç¸¦ À§ÇÑ ¾ãÀº ÀýÆíÀ» ¸¸µé ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. È¿À²ÀûÀÎ Á¶Á÷ 󸮴 Á¤È®ÇÑ Áø´Ü, ƯÈ÷ ¾Ï ¹× ±âŸ Áúº´ÀÇ Áø´Ü¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ Á¤¹Ð ÀÇ·á¿Í Á¶±â ¹ß°ß¿¡ ÀÇÁ¸ÇÏ°Ô µÊ¿¡ µû¶ó Á¶Á÷ ó¸® ½Ã½ºÅÛÀº ºÐ¼®À» À§ÇÑ °íǰÁú Á¶Á÷ »ùÇÃÀ» Á¦°øÇÏ´Â µ¥ ÀÖ¾î Á¡Á¡ ´õ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È´Â ÃֽŠÁ¶Á÷ ó¸® ½Ã½ºÅÛÀÇ Áß¿äÇÑ Æ¯Â¡ÀÌ µÇ¾î ´ë·®ÀÇ »ùÇÃÀ» ó¸®ÇÏ´Â ÀÓ»ó ½ÇÇè½Ç¿¡¼ Áß¿äÇÑ Ã³¸®·® Çâ»ó°ú ÀÎÀû ¿À·ù °¨¼Ò¸¦ ½ÇÇöÇϰí ÀÖ½À´Ï´Ù.
Á¶Á÷ ó¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?
Á¦Ç° À¯Çü¿¡´Â ÀÚµ¿ Á¶Á÷ ó¸® ÀåÄ¡, ½Ã¾à ±â¹Ý ½Ã½ºÅÛ, ¼öµ¿ ó¸® ½Ã½ºÅÛÀÌ ÀÖÀ¸¸ç, ÀÚµ¿È ½Ã½ºÅÛÀº È¿À²¼º°ú Á¤È®¼ºÀ¸·Î ÀÎÇØ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. Á¶Á÷ ó¸® ½Ã½ºÅÛÀÇ ÀÀ¿ë ºÐ¾ß¿¡´Â ¾Ï Áø´Ü, Áúº´ Á¶»ç, ½Å¾à °³¹ß, Çмú ¿¬±¸ µîÀÌ ÀÖ½À´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ´Â º´¿ø, Áø´Ü ¿¬±¸¼Ò, ¿¬±¸±â°ü, Á¦¾àȸ»ç µî ´Ù¾çÇÕ´Ï´Ù. ¾Ï À¯º´·üÀÇ Áõ°¡¿Í »ý°Ë °Ë»çÀÇ Áõ°¡´Â ÀÓ»ó ½ÇÇè½Ç¿¡¼ ÷´Ü Á¶Á÷ ó¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÐÀÚ º´¸®ÇÐ ¹× ¸é¿ªÁ¶Á÷ÈÇп¡¼ Á¶Á÷ »ùÇÃÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¶Á÷ ó¸® Àåºñ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
Á¶Á÷ ó¸® ½Ã½ºÅÛÀÇ Ãֽбâ¼ú ¹ßÀüÀº?
Á¶Á÷ ó¸® ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀüÀº ÀÚµ¿È, È¿À²¼º ¹× »ùÇà ǰÁú¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ÀÚµ¿ Á¶Á÷ ÇÁ·Î¼¼¼´Â ÀÌÁ¦ ³ôÀº 󸮷® ±â´ÉÀ» Á¦°øÇÏ¿© ½ÇÇè½Ç¿¡¼ ´õ ¸¹Àº »ùÇÃÀ» ´õ ªÀº ½Ã°£¿¡ ó¸®ÇÏ¸é¼ Á¤È®¼ºÀ» À¯ÁöÇϰí Á¶Á÷ ¼Õ»óÀÇ À§ÇèÀ» ÁÙÀÌ¸é¼ ´õ ¸¹Àº »ùÇÃÀ» ó¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, Á¶Á÷ 󸮿¡ »ç¿ëµÇ´Â ½Ã¾à°ú ÈÇÐÁ¦Ç°ÀÇ ¹ßÀüÀ¸·Î Á¤È®ÇÑ Áø´Ü¿¡ ÇʼöÀûÀÎ ¼¼Æ÷ ±¸Á¶ÀÇ º¸Á¸¼ºÀÌ Çâ»óµÇ°í ÀÖÀ¸¸ç, AI ±â¹Ý À̹ÌÁö ºÐ¼®°ú °áÇÕµÈ µðÁöÅÐ º´¸®ÇÐÀº Á¶Á÷ »ùÇÃÀ» º¸´Ù È¿À²ÀûÀ¸·Î ºÐ¼®Çϰí ÇØ¼®ÇÏ´Â ´É·ÂÀ» Çâ»ó½ÃÄÑ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ·Îº¿ Çڵ鸵 ½Ã½ºÅÛ°ú ½º¸¶Æ® ±â¼úÀÇ ¹ßÀüÀº ¿öÅ©Ç÷ο츦 °£¼ÒÈÇÏ¿© º¸´Ù ÀϰüµÇ°í Ç¥ÁØÈµÈ Á¶Á÷ 󸮸¦ °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.
Á¶Á÷ ó¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
Á¶Á÷ ó¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ¾Ï Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÚµ¿È ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. º¸´Ù ºü¸£°í Á¤È®ÇÑ Áø´Ü µµ±¸ÀÇ Çʿ伺À¸·Î ÀÎÇØ °Ë»ç½ÇÀº ´õ ³ôÀº 󸮷®°ú ´õ ³ªÀº »ùÇà ǰÁúÀ» Á¦°øÇÏ´Â ÀÚµ¿È Á¶Á÷ ó¸® ½Ã½ºÅÛÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ºÐÀÚÁø´Ü, ƯÈ÷ Á¾¾çÇÐ ºÐ¾ßÀÇ È®ÀåÀº °í±Þ Á¶Á÷ ó¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÓ»ó½ÃÇè ¹× ½Å¾à °³¹ß¿¡¼ Á¶Á÷ »ùÇÃÀÇ »ç¿ë È®´ëµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½Ã¾à ¹× ÈÇÐÁ¦Ç°ÀÇ ±â¼ú Çõ½ÅÀº Áø´Ü ½ÇÇè½ÇÀÇ Ã³¸® ½Ã°£ ´ÜÃà¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ºÎ¹®
Á¦Ç° À¯Çü(¼Ò¿ë·®, Á߿뷮, °í¼Ó ´ë¿ë·®)
AI ÅëÇÕ
¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.
Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.
°ü¼¼ ¿µÇâ °è¼ö
Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Global Tissue Processing Systems Market to Reach US$570.1 Million by 2030
The global market for Tissue Processing Systems estimated at US$433.8 Million in the year 2024, is expected to reach US$570.1 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Small Volume, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$251.3 Million by the end of the analysis period. Growth in the Medium Volume segment is estimated at 3.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$117.1 Million While China is Forecast to Grow at 4.4% CAGR
The Tissue Processing Systems market in the U.S. is estimated at US$117.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$90.0 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.
Global Tissue Processing Systems Market - Key Trends and Drivers Summarized
Why Are Tissue Processing Systems Critical for Pathology and Diagnostics?
Tissue processing systems are vital tools in pathology laboratories, ensuring that biological tissues are properly prepared for examination, diagnosis, and research. The process involves fixing, dehydrating, clearing, and embedding tissue samples in paraffin wax, which enables histologists and pathologists to create thin slices for microscopic examination. Efficient tissue processing is critical for accurate diagnosis, particularly in cancer and other disease diagnostics. As healthcare systems become more reliant on precision medicine and early detection, tissue processing systems are playing an increasingly important role in delivering high-quality tissue samples for analysis. Automation has become a key feature of modern tissue processing systems, enhancing throughput and reducing human error, which is critical in clinical laboratories handling large volumes of samples.
What Are the Key Segments in the Tissue Processing Systems Market?
Product types include automated tissue processors, reagent-based systems, and manual processing systems, with automated systems dominating the market due to their efficiency and accuracy. Applications of tissue processing systems include cancer diagnostics, disease research, drug discovery, and academic research. End-users range from hospitals and diagnostic laboratories to research institutes and pharmaceutical companies. The growing prevalence of cancer and the rising number of biopsy tests are driving the demand for advanced tissue processing systems in clinical laboratories. Additionally, the growing use of tissue samples in molecular pathology and immunohistochemistry is expanding the market for tissue processors.
What Are the Latest Technological Advancements in Tissue Processing Systems?
Technological advancements in tissue processing systems have focused on automation, efficiency, and sample quality. Automated tissue processors now offer high-throughput capabilities, enabling laboratories to process more samples in less time while maintaining precision and reducing the risk of tissue damage. Additionally, advancements in reagents and chemicals used in tissue processing have improved the preservation of cellular structures, which is critical for accurate diagnosis. Digital pathology, combined with AI-based image analysis, is also impacting the market by enhancing the ability to analyze and interpret tissue samples more efficiently. Furthermore, advancements in robotic handling systems and smart technologies are helping to streamline workflows, allowing for more consistent and standardized tissue processing.
What Factors Are Driving Growth in the Tissue Processing Systems Market?
The growth in the tissue processing systems market is driven by several factors, including the increasing demand for cancer diagnostics, the rising prevalence of chronic diseases, and advancements in automation technologies. The need for faster, more accurate diagnostic tools is prompting laboratories to adopt automated tissue processing systems that offer higher throughput and better sample quality. The expansion of molecular diagnostics, particularly in oncology, is also driving demand for advanced tissue processing solutions. Additionally, the growing use of tissue samples in clinical trials and drug discovery is contributing to the expansion of the market. Innovations in reagents and chemicals, combined with the growing focus on reducing turnaround times in diagnostic labs, are further fueling market growth.
SCOPE OF STUDY:
The report analyzes the Tissue Processing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Small Volume, Medium Volume, Rapid High Volume)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 23 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.